Novartis and its Alcon division delivered a good performance in the third quarter of 2014.

Novartis recorded net sales of CA$16.5 billion, a 4% increase compared with the same period last year.

Alcon’s third-quarter sales were CA$3 billion, a 5% increase over the same period in 2013. Alcon reported an increase of 3% in its pharmaceutical ophthalmic products, and a 3% increase in its vision care products. In the vision care segment, the strong sales growth of Dailies Total and AirOptix Colors contact lenses offset a decline in contact lens care solutions.

For more information: http://www.novartis.com/downloads/investors/financial-results/quarterly-results/q3-2014-media-release-en.pdf

Abbott reported a sales increase of 5.8% over last year for the third quarter of 2014.

Abbott’s total worldwide sales were CA$5.7 billion in the third quarter of 2014. Although sales in the Medical Devices sector dropped 1% compared with the same period last year, sales in the Optics sector rose by 5.2%. The company reported total revenues of CA$336 million, CA$124 million of which was in the United States (a 14% increase over the same period last year).

For further information: http://abbott.mediaroom.com/2014-10-22-Abbott-Reports-Third-Quarter-2014-Results

Hoya posted an 18.6% increase in its profits for the second quarter of 2014, compared with the same period in 2013.

The Japanese company reported CA$1.2 million in sales (121,242 million yen) in this quarter. Its after-tax profit was almost CA$275,000 (27,323 million yen).

In the Life Care segment, which includes ophthalmic, contact and intraocular lenses, sales increased by 20.5%, compared with the same period last year, to CA$759,000 (75,493 million yen). This growth was driven by a significant increase in sales in overseas markets and through the inclusion of Seiko Optical Products.

For more information: http://v4.eir-parts.net/v4Contents/View.aspx?template=announcement&sid=20528&code=7741